GoIndustry DoveBid appoints SVP of North American sales
Romie Castelli returns to the company he originally joined in 2002
Castelli takes responsibility for directing GoIndustry DoveBid’s sales and marketing efforts in North America. He was most recently senior vice president of corporate services at Great American Group. Before that, as senior vice president of North America at DoveBid, prior to its acquisition by GoIndustry in 2008, he was responsible for the DoveBid sales force.
Castelli joined DoveBid in 2002 through acquisition, having been vice president of sales for ZoneTrader.
You may also like
Finance
![Fulcrum Therapeutics merges with Slate Medicines in $245m-backed deal]()
Fulcrum Therapeutics merges with Slate Medicines in $245m-backed deal
The all-stock merger sees Fulcrum rebuild following its pociredir discontinuation, with the combined entity focusing on SLTE-1009 — a monoclonal antibody in development for migraine and headache disorders — funded into 2029
Finance
![Prescient completes integration of Uptake and Dolon under single global brand]()
Prescient completes integration of Uptake and Dolon under single global brand
Prescient Healthcare Group has completed the integration of Uptake and Dolon, creating a 550-strong life sciences consultancy spanning commercial strategy, medical affairs, competitive intelligence and market access
Finance
![AlzeCure receives $12m upfront as NeuroRestore Alzheimer's platform licensing deal with QuantumCell closes]()
AlzeCure receives $12m upfront as NeuroRestore Alzheimer's platform licensing deal with QuantumCell closes
The payment — comprising $7m in licence fees and $5m direct investment — kicks off a collaboration worth more than $2.2bn in potential milestones, with QuantumCell assuming global rights to ACD856 and the NeuroRestore platform
Manufacturing
![DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction]()
DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction
The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the use of personalised and time-sensitive genetic medicines grows
